Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
HeartBeam (BEAT)
NASDAQ:BEAT
Holding BEAT?
Track your performance easily
Earnings Data
Report Date
Mar 20, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.19Last Year’s EPS
$0.07Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2024
|% Change Since: 4.29%
|Next Earnings Date:Mar 20, 2025
Earnings Call Sentiment|Neutral
The earnings call revealed a strong focus on innovation and strategic positioning for future growth, highlighted by progress in FDA submissions, significant clinical evidence, and industry recognition. However, financial losses and uncertain immediate revenue projections are notable concerns. Overall, the sentiment suggests cautious optimism as the company prepares for commercialization.Company Guidance
During the HeartBeam Q3 2024 earnings call, the guidance highlighted several key metrics and strategic updates. The company is progressing with its FDA submission for a foundational clearance, which is pivotal for its cable-free 12-lead ECG technology. HeartBeam aims to disrupt markets valued over $100 billion annually in the U.S. alone. Financially, the net loss for Q3 was nearly $5 million, with $3.3 million cash used in operating activities. The cash balance stood at $5.8 million at the end of September. With 17 patents and significant clinical evidence, including 9 peer-reviewed publications, HeartBeam is preparing for commercialization in 2025 and plans to launch an early access program post-FDA clearance. The company is also strategically managing cash burn and engaging with supportive shareholders for future financing.FDA Submission Progress
HeartBeam's 510(k) submission is progressing through active review by the FDA. The company remains optimistic about achieving foundational FDA clearance, which is a major milestone for future submissions.
Innovative Cardiac Care Technology
HeartBeam has developed a cable-free 12-lead ECG using a vector-based approach, capturing high-resolution heart signals. The technology addresses multiple large markets worth over $100 billion annually in the U.S.
Significant Clinical Evidence
HeartBeam has 9 peer-reviewed publications from studies with over 500 patients. Upcoming presentations at the American Heart Association Conference will further demonstrate the technology's potential.
Recognition and Awards
HeartBeam was named Rising Star at the Digital Health Hub Foundation Awards and received a MedTech Breakthrough Award for best new ECG technology solution.
Management Team Expansion
HeartBeam has strengthened its team with new appointments, including Tim Cruickshank as CFO and Lance Myers as Chief AI Officer, positioning the company for commercialization.
---
BEAT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
BEAT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | $2.33 | $2.57 | +10.30% |
| Aug 14, 2024 | $2.27 | $2.31 | +1.76% |
| May 09, 2024 | $2.01 | $1.96 | -2.49% |
| Mar 20, 2024 | $2.20 | $2.31 | +5.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does HeartBeam (BEAT) report earnings?
HeartBeam (BEAT) is schdueled to report earning on Mar 20, 2025, TBA Not Confirmed.
What is HeartBeam (BEAT) earnings time?
HeartBeam (BEAT) earnings time is at Mar 20, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BEAT EPS forecast?
BEAT EPS forecast for the fiscal quarter 2024 (Q4) is -$0.19.
---